Preclinical Evaluation and Optimization of a Cell Therapy Using Human Cord Blood-Derived Endothelial Colony-Forming Cells for Ischemic Retinopathies.

MLA

Reid, Emma, et al. “Preclinical Evaluation and Optimization of a Cell Therapy Using Human Cord Blood-Derived Endothelial Colony-Forming Cells for Ischemic Retinopathies.” Stem Cells Translational Medicine, vol. 7, no. 1, Jan. 2018, pp. 59–67. EBSCOhost, https://doi.org/10.1002/sctm.17-0187.

APA

Reid, E., Guduric-Fuchs, J., O’Neill, C. L., Allen, L.-D., Chambers, S. E. J., Stitt, A. W., & Medina, R. J. (2018). Preclinical Evaluation and Optimization of a Cell Therapy Using Human Cord Blood-Derived Endothelial Colony-Forming Cells for Ischemic Retinopathies. Stem Cells Translational Medicine, 7(1), 59–67. https://doi.org/10.1002/sctm.17-0187

Chicago

Reid, Emma, Jasenka Guduric-Fuchs, Christina L O’Neill, Lynsey-Dawn Allen, Sarah E J Chambers, Alan W Stitt, and Reinhold J Medina. 2018. “Preclinical Evaluation and Optimization of a Cell Therapy Using Human Cord Blood-Derived Endothelial Colony-Forming Cells for Ischemic Retinopathies.” Stem Cells Translational Medicine 7 (1): 59–67. doi:10.1002/sctm.17-0187.